Pralsetinib (Gavreto): Treatment of metastatic non-small-cell lung cancer in patients positive for RET fusions
Publication Date
3-21-2022
Content Type
Article
PubMed ID:
Citation
American Journal of Health-System Pharmacy (2022) 79(7):527-533
3-21-2022
Article
American Journal of Health-System Pharmacy (2022) 79(7):527-533